Synthetic Biologics Inc
Synthetic Biologics Inc (NYSE:SYN) shareholders are celebrating today after the biotech company reported above-consensus first-quarter results, sending shares up 23%.
While remaining bullish on the stock, FBR analyst Edward White reduced his price target from $10.00 to $9.00, to reflect the increase in diluted share count. The analyst rates SYN an Outperform.
White wrote, “SYN reported 1Q16 EPS of ($0.12), versus our estimate of ($0.13) and the FactSet consensus estimate of ($0.13). G&A and R&D expenses for the quarter were $2.4M and $8.2M, above our G&A estimate of $1.9M and below our R&D estimate of $9.9M, respectively.”
The analyst continued, “On the earnings call, management reaffirmed 2016 milestones and developmental goals for its pipeline. We expect to see detailed data presentations from Dr. Mark Pimentel supporting the previously reported top-line data from the two Phase II trials for SYN-010 at Digestive Disease Week (DDW) 2016, which will be held May 21–24. Synthetic continues to aggressively enroll patients in its Phase IIb proof-of-concept trial of SYN-004 for the prevention of C. difficile (CDI), with over 185 patients enrolled to date. In addition, Synthetic is conducting a second Phase IIa clinical trial in SYN-004, which will evaluate the GI antibiotic-degrading ability and safety of SYN-004 in the presence of the proton pump inhibitor (PPI) esomeprazole in healthy subjects with functioning ileostomies.”
According to TipRanks.com, which measures analysts’ and bloggers’ success rate based on how their calls perform, analyst Edward White has a yearly average return of -10% and a 27% success rate. White has a -9% average return when recommending SYN, and is ranked #3627 out of 3899 analysts.
As of this writing, all the 6 analysts polled by TipRanks rate Synthetic Biologics stock a Buy. With a return potential of 240%, the stock’s consensus target price stands at $7.40.
Cantor analyst Youssef Squali reiterated a Buy rating on shares of Yelp Inc (NYSE:YELP), with a price target of $38, after the online business-review company reported solid first-quarter results, driven by Local where revenue growth accelerated on better-than-expected ad budget fulfillment and above avg salesperson productivity.
Yelp shares reacted to the results, rising 22% to $26.22 on heavy volume, making it among the top winners today.
Squali commented, “Re-acceleration in local ad account and revenue growth drove better-than-expected 1Q:16 results, and caused management to raise its FY:16 guidance. After several quarters of decelerating growth, a combination of aggressive hiring of sales people in 4Q:15 and 1Q:16 and the launch of a marketing campaign to increase awareness for the brand drove what looks like a reversal in growth momentum, positioning the company well for the rest of 2016. We remain constructive on YELP given 1) its exclusive focus on the rapidly growing local ad market, 2) its improving operating metrics, 3) its organic scale and network effect, and 4) compelling valuation relative to growth/profitability potential.”
According to TipRanks.com, which measures analysts’ and bloggers’ success rate based on how their calls perform, analyst Youssef Squali has a yearly average return of 13.6% and a 62.2% success rate. Squali has a -2.3% average return when recommending YELP, and is ranked #13 out of 3899 analysts.
Out of the 32 analysts polled by TipRanks, 12 are bullish on Yelp stock, 17 are neutral, and 3 are bearish. With a return potential of 7%, the stock’s consensus target price stands at $27.44.